Automated Cell Shakers Market Trends
The size of the global automated cell shakers market was valued at USD 698.9 million in 2024 and is expected to grow at a CAGR of 7.10% during the period from 2025 to 2030. The growing need for sophisticated laboratory automation systems is heavily driving the use of automated cell shakers.
Research centers and pharmaceutical firms are looking to automated systems to maximize the efficiency of cell culture processes. These systems reduce human errors, ensure consistency, and increase throughput in biological research. The demand for higher reproducibility in cell-based assays is prompting, employing equipment that accurately controls variables like shaking speed and temperature. This transition is picking up pace in regions dedicated to high-throughput drug screening and large-scale bioproduction.
Increased investment in biotechnology and biopharmaceutical research drives demand for superior laboratory equipment. Biologics manufacturing companies depend on effective mixing technology to provide high cell viability and steady productivity. Automated cell shakers are vital by providing programmable conditions and stable incubation environments. Such functions enable accuracy and reproducibility in cell culture processes. Academic research institutions are increasingly using automated mixing equipment to further gene therapy and regenerative medicine research. The growing pipeline of biologic drugs is likely to support robust demand for these technologies in research and development.
The increasing prevalence of chronic diseases fuels greater investment in cell-based research for the development of targeted therapies. As cell culture methods become more sophisticated, laboratories need equipment that provides consistent performance and low levels of contamination. Automated cell shakers meet these requirements by facilitating standardized workflows and minimizing manual handling. Their integration with laboratory information management systems (LIMS) increases data tracking and operational efficiency. This integration enhances reproducibility in different research applications and simplifies processes. Consequently, the demand for automated cell shakers is gradually growing in research, clinical, and industrial settings.
Report Coverage & Deliverables
- Competitive benchmarking
- Historical data & forecasts
- Company revenue shares
- Regional opportunities
- Latest trends & dynamics
Advancements in Laboratory Automation Technology
The market is witnessing good momentum as a result of accelerated developments in laboratory automation. For example, IntelliStack Incubator Shakers and COâ‚‚ Incubator Shakers now have programmable shaking modes, real-time observation, and compatibility with larger lab systems, enhancing process control. These features minimize human error and enhance operational efficiency in research as well as industrial laboratories. Automation also enables higher throughput and uniformity, which are essential in reproducible cell culture experiments. As labs keep upgrading, the need for high-tech automated shakers is increasing consistently.
Increasing Demand for Biopharmaceuticals
The biopharmaceutical growth surge drives the industry strongly. The equipment offers controlled environments essential for consistent cell growth, critical to drug development and protein production. Large-scale culture operations are enhanced with automated shakers through the provision of consistent agitation and optimal conditions for growth. The growing demand for cell-based treatments and personalized medicine add to market growth acceleration. Automated systems become the hub of production processes as biopharma manufacturing increases.
The BioProcess International pie chart indicates that mammalian cell culture systems, primarily based on CHO cells, account for approximately 67.7% of biomanufacturing capacity worldwide. This is due to increased demand for high-order biopharmaceuticals such as monoclonal antibodies, which are produced by sophisticated methods. Microbial systems and newer platforms such as gene and cell therapies have smaller portions, with gene therapy being under 0.5%. In response to increasing demand, the sector is enhancing productivity via increased titers and the implementation of single-use technologies in lieu of growing big facilities. Such a transition to efficiency and flexibility enables faster, more scalable manufacturing of biologics. Demand for automated cell shakers should thus grow as they allow consistent, high-throughput cell culture, critical for contemporary biomanufacturing.
Market Concentration & Characteristics
The sector is characterized by ongoing innovation, with the pressure for more efficient and adaptable solutions in cell culture processes. Firms concentrate on developing shaker designs that improve in terms of features such as temperature and speed control, real-time observation, and automation, which enhance cell growth and productivity. Advances in material technology and compatibility with other lab automation equipment are also essential in responding to increasing demands for high-throughput processing. As biotechnology, pharmaceutical, and agricultural research speeds up, the market will continue to experience more innovations in shaker technology. Strong R&D companies establish themselves as market leaders in this competitive industry.
The sector has experienced moderate mergers and acquisitions (M&A) activity, with firms looking to diversify their product offerings and access new technologies. M&A is a strategic method to expand market footprint, more specifically through the acquisition of companies with niche shaker technologies or complementary automation technology. For example, in May 2023, Cytiva and Pall Life Sciences finalized the integration to create a worldwide leader in biotechnology solutions and innovation. The merger strengthened their bioprocessing capabilities and improved their capacity to aid in biologics and vaccine development. This strategic action fortified their position in the biotechnology industry, speeding up innovation and efficiency.
Such mergers help players enhance their competitive advantage by providing more holistic solutions to customers in the manufacturing and research industries. Strategic acquisitions also facilitate the incorporation of innovative technologies into established platforms. Nevertheless, the extent of M&A is quite low compared to other biotechnology industries.
Regulation largely defines the industry, especially in life sciences and the pharmaceutical industries, where strict adherence to Good Manufacturing Practice (GMP) guidelines is essential. Producers need to be certain their goods are compliant with strict health and safety standards for both clinical and commercial applications. Regulatory agencies such as the FDA and EMA tend to have definite regulations for automated laboratory instruments used in the development of pharmaceuticals or diagnostic procedures. This regulatory climate persuades firms to invest in obtaining compliant and certified products, while posing challenges of approval time and cost. Firms have to work their way through these regulations to attain market entry and succeed in the long term.
Product development within the industry is spurred by the necessity of serving wide research applications, ranging from simple cell culture to large-scale manufacturing. Producers further diversify their product lines by creating multiple-function shakers, including sensors and real-time analytics. Shakers with special applications for markets such as microbiology, stem cells, or the discovery of drugs are more common. Product diversification allows businesses to recruit new consumers and satisfy the changing demands of different industries. Increased customization and scalability features are also part of product growth in this industry.
Firms are widening operations worldwide to grab burgeoning opportunities. Mature firms in Europe and North America concentrate on high-performance products for the pharmaceuticals and biotech industries. For example, in March 2023, Kuhner Shaker reported through its website that it had finished a new production hall at its headquarters in Birsfelden, Switzerland. The building measured several thousand square meters and accommodated more than 70 staff members in major departments. It was engineered to increase manufacturing capacity for shaker systems, bioreactors, and ancillary parts. In Asia-Pacific, firms invest in in-country manufacturing and strategic collaborations to improve accessibility. Latin America and the Middle East are also expanding as demand for research tools increases. The region by extension enables firms to tap into diversified customer bases and conform to local regulations. The approach assists in fulfilling the distinctive demands of different markets.
Product Insights
The automated cell shakers segment led the market with the highest revenue share of 36.84% in 2024 due to rising demand for high-throughput screening and lab process automation. Expanding dependency on reproducible and effective culture conditions in cell-based research has increased the application of these systems. The capability of automated shakers to process high sample volume with less human intervention has dramatically enhanced productivity. For example, Thermo Fisher Scientific launched its Cytomat 2 C-LiN series with built-in shaking and incubation capabilities, optimized for automated drug discovery workflows. Increased uptake in pharmaceutical, biotech, and academia has further driven growth. Improved integration with bioreactors and liquid handling platforms has enhanced their application in sophisticated workflows.
Orbital shakers segment is expected to register the highest CAGR during the forecast period, driven by rising applications in tissue engineering, stem cell culture, and vaccine production. Their ability to accommodate multiple applications, such as microbial culture and protein expression, has expanded their application base. User-friendly, energy-saving systems with programmable capabilities have made them a preferred choice in purchasing decisions at small and medium-sized laboratories. For instance, Benchmark Scientific Inc.'s newly introduced Incu-Shaker Mini Plus provides small orbital motion with digital control that is suitable for low-volume, space-restricted research environments. Gains in platform stability and noise reduction have enhanced their applicability to delicate environments. Even vessel compatibility with various types of vessels, including microplates and flasks, has rendered orbital shakers a first choice.
Application Insights
The drug development area ruled the market with the highest revenue share of 37.81% in 2024, owing to increasing applications of cell-based assays in toxicity testing, compound screening, and lead optimization. Precise and uniform cell culture conditions demand have established automated cell shakers as crucial devices in early- and late-stage drug development. These equipment ensure consistent mixing and enhanced gas exchange, mitigating variability in assay results. Increased focus on speeding up timelines and diminishing costs has been driving investment into automated systems. Coupling with robotics and live data capture systems has further minimized workflows. Even more complexity has been added in biologic drug development, along with more reliance on advanced shaking technologies.
Regenerative medicine will grow at the highest CAGR during the period of forecasting on account of rising research in the areas of stem cells, tissue engineering, and organoid cultures. Automated cell shakers facilitate the precise culture of sensitive cell types in ideal environmental conditions. They enable consistent shear forces, minimizing cell damage over long culture times. One such example is Kuhner's LT-X shaker, which has found extensive use in regenerative medicine laboratories for its accuracy in working with sensitive cell lines. Increased investments in personalized therapies and 3D bioprinting have driven demand for scalable and reproducible culture solutions. Ongoing advances in shaker designs, such as multi-level platforms and real-time monitoring capabilities, have enabled increasingly sophisticated experimental apparatuses.
End-use Insights
The segment of pharmaceutical companies was the market leader with the highest revenue percentage of 38.45% in 2024, due to growing emphasis on biologics and high-volume cell culture operations. Automated cell shakers provide efficiency, precision, and reproducibility required for mass production of drugs. Compatibility with upstream and downstream bioprocessing equipment has enabled hassle-free tracking of data and quality control. For example, Sartorius' Certomat CT Plus orbital shaker is extensively applied in GMP-certified drug plants for maintaining rigorous process parameters. The demand for reduced man power and eliminated risk of contamination has further augmented adoption. Expansion in the pipeline of cell-based therapeutics and vaccines has further boosted dependence on automated machinery.
The CDMOs & CMOs market is anticipated to expand at the highest CAGR during the forecast period, driven by increased outsourcing of cell-based manufacturing and research activities. These institutions need flexible, scalable equipment to address various client requirements in preclinical and commercial phases. Automated cell shakers offer the standardization and throughput necessary for contract-based processes. A recent case in point is INFORS HT's Multitron Pro, which has found increased application among CMOs due to its modular concept and flexibility to adopt different shaking modes. The shift towards time-saving, cost-effective manufacturing paradigms has positioned automation as a key investment. CDMOs & CMOs will be required to diversify their automated equipment offerings with growing demand for custom biologics and gene therapies.
Regional Insights
North America automated cell shakers market dominated due to the strong presence of biotechnology and pharmaceutical firms such as Thermo Fisher Scientific and Agilent Technologies. Advanced laboratory infrastructure supports frequent high-performance cell culture equipment adoption in research hubs like Boston and San Diego. High research spending across academic and private institutions continues to raise demand for automated systems. Strategic collaborations, such as those between Harvard University and biotech startups, increase the usage of lab automation tools. Rising demand for precision medicine drives investments in cell culture technologies used in oncology and immunotherapy research. Continuous innovation by regional companies boosts the integration of advanced shaking platforms in commercial laboratories.
U.S. Automated Cell Shakers Market Trends
Automated cell shakers market in the U.S. demonstrates high growth owing to high demand for scalable cell culture technologies at institutions such as the National Institutes of Health (NIH). Increasing biologics and cell therapy pipelines at companies such as Amgen and Gilead compels pharmaceutical corporations to incorporate automation. The availability of major market players such as Eppendorf and BioTek Instruments enables access to a broad variety of cell shakers. Accelerated adoption of high-throughput screening within CROs such as Charles River Laboratories amplifies dependence on automated equipment. Expansion in contract research services spurs investment in effective lab equipment to minimize process time. Strong intellectual property infrastructure promotes innovation in automated cell shaking technology applied in vaccine manufacturing.
Europe Automated Cell Shakers Market Trends
The European market for automated cell shakers shows steady growth as a result of robust demand from biomanufacturing industries in nations like the Netherlands and Switzerland. Growing emphasis on laboratory productivity fuels the use of automation instruments in research facilities like the European Molecular Biology Laboratory (EMBL). Growth in biosimilar manufacturing by firms like Sandoz enhances demand for scalable, accurate cell culture techniques. A well-developed academic and healthcare infrastructure supports recurring market penetration. Alliances between biotech companies and universities, like the Oxford-AstraZeneca partnership, enable wider applications of automated laboratory systems. Focus on minimizing human error and maximizing repeatability increases the appeal of computerized shakers in both clinical and academic environments.
The market for UK automated cell shakers is propelled by the expansion in pharma R&D, especially through organizations like GlaxoSmithKline. Increased demand for reproducible cell culture results in the encouragement of laboratory automation within university hospitals and biotechnology companies. The availability of top-tier research centers like the Francis Crick Institute facilitates high-end laboratory equipment adoption. Moreover, increased spending on biologics such as monoclonal antibodies drives demand for heavy-duty shaking systems. A robust clinical trials environment in areas like Cambridge underpin the adoption of automation to enhance throughput, and the market gains from growing interest in minimizing manual intervention in repetitive lab tasks among biopharma firms.
The automated cell shakers market in Germany is essential with its robust life sciences industry and institutions like the Max Planck Institutes. Strict pharmaceutical production standards at companies like Bayer heighten the demand for accurate and dependable laboratory equipment. Large biotech clusters in Berlin and Munich facilitate collaboration and implementation of superior technologies. Expansion in uses of bioprocessing for such therapies as CAR-T necessitates stable and reproducible cell culture environments. Focus on quality and standardization of processes facilitates the implementation of automated shaking systems in GMP-compliant laboratories. Strong emphasis on technology excellence propels demand for programmable and customizable products from German producers.
Asia Pacific Automated Cell Shakers Market Trends
The Asia Pacific market for automated cell shakers captures the highest growth rate, fueled by growing pharmaceutical and biotech industries in India, South Korea, and Singapore. Growing adoption in research laboratories fuels regional market growth, with A*STAR in Singapore among institutions committing to investments in robotic cell culture systems. Growing industrialization and enhanced laboratory capabilities entice investments in laboratory equipment in urban centers. Schools concentrate on the upgrading of laboratory infrastructure, a trend witnessed through developments at the Indian Institute of Science and Tsinghua University. Increasing demand for healthcare creates demand for growth in drug development and cell-based research into ailments like diabetes and cancer. Access to local manufacturing such as from Esco Lifesciences increases the affordability and availability of the product.
China cell shakers market is expanding quickly as a result of growth in life sciences research and biomanufacturing facilities in urban areas such as Shanghai and Shenzhen. Growing pharmaceutical R&D investment by players like WuXi AppTec fuels demand for laboratory automation solutions. Growth in biologics and vaccine development, including COVID-19 vaccine development, sustains broader adoption of automated shakers. Academic research and biotech start-ups drive growth in the adoption of cell culture equipment in university-affiliated laboratories. Local production and innovation by companies like Mindray enhance access to automated machinery in high-throughput settings. Widespread emphasis on research infrastructure modernization further enhances market presence.
The market for automated cell shakers in Japan remains steady because of its highly developed healthcare and research setup, which is backed by research institutions like RIKEN. Sustained R&D in biologics and regenerative medicine at pharma firms like Takeda continues to augment the need for trustworthy laboratory automation solutions. Reliability and precision support the application of shaking platforms that are programmable in stem cell research. Increased use of robotics and laboratory automation within pharma firms fuels demand for combined systems. Biomedical research, fueled by an aging population, boosts the application of cell-based assays in age-related diseases. Collaborations between academia and industry promote continuous innovation in lab technologies across regional research centers.
Middle East & Africa Automated Cell Shakers Market Trends
The Middle East and Africa automated cell shakers market is slowly growing as a result of increased investments in life sciences facilities in cities like Dubai and Johannesburg. Research centers are upgrading laboratory facilities to international standards in biotechnology and pharma. Expansion in private healthcare services like specialty hospitals increases the demand for sophisticated research and diagnostic equipment. Local collaborations with international biotech companies like Roche increase access to automation technology in university-associated laboratories. Training and education through workshops and collaborations improve the use of lab equipment. Growing interest in precision medicine and personalized therapy favors the application of automated shaking platforms in molecular biology research.
Saudi Arabia cell shakers market is observing market expansion supported by diversification into biotech and pharmaceutical applications through country programs like Vision 2030. New centers like the King Abdullah International Medical Research Center sustain the demand for automatic laboratory instruments. Growth of health services in the cities of Riyadh promotes adoption of effective and expandable research instrumentation. Investment in scientific research by institutions like KAUST encourages the application of advanced laboratory systems. Increased biotech start-ups encourage demand for automated cell culture technologies in therapeutic research. Strategic partnerships with global companies like Pfizer improve access to cutting-edge shaking and incubation technologies.
Automated cell shakers market in Kuwait is facilitated by lab infrastructure modernization in public and private healthcare facilities. Greater emphasis on medical research and diagnostics in universities such as Kuwait University creates higher demand for precision equipment. Spending in healthcare and life sciences forges demand for streamlined laboratory workflows and advanced cell culture techniques. Collaborations with international institutions, such as those of the UK and Germany, foster technology adoption and knowledge transfer. The establishment of research parks and biotech incubators facilitates access to sophisticated laboratory equipment. Growing academic interest in biotechnology lends impetus to greater use of automation in molecular and cell biology laboratories.
Key Automated Cell Shakers Companies Insights
The following chart offers comparative analysis of four key players in the automated cell shakers market. Thermo Fisher Scientific is ranked high on all parameters, which generally signifies overall market strength. Extensive product range, inorganic growth strategies, and wide global presence position it as a leader in the market. Eppendorf AG is also ranked highly across all three parameters, indicating high investment in R&D and growth. Kuhner Shaker positioning is predictive of a robust core offerings strength, but potentially less extreme in partnership deals, acquisitions, or pipeline growth. Simultaneously, Corning Incorporated exhibits medium-to-high performance, especially in strategic programs.
Major players employed most strategies, such as collaborations, partnerships, and new product launches. Thermo Fisher Scientific launched the fully integrated IntelliStack Incubator and COâ‚‚ Incubator Shakers for accurate and reproducible cell culture control to gain a larger market share worldwide.
Major players in the automated cell shakers market are implementing different initiatives to enhance their presence and expand the reach of their products and services. Initiatives like expansion activities and partnerships are major in driving the market growth.
Key Automated Cell Shakers Companies
The following are the leading companies in the automated cell shakers market. These companies collectively hold the largest market share and dictate industry trends.
- Thermo Fisher Scientific Inc.
- Eppendorf AG
- Ohaus Corporation
- Benchmark Scientific
- Corning Incorporated
- Grant Instruments
- Kuhner Shaker
- Infors AG
- Boekel Scientific
- VELP Scientifica Srl
Recent Developments
-
In March 2025, Caron Scientific introduced the 7406 Incubator Shaker at the EU Advanced Therapies conference. The instrument had the largest capacity in a small footprint, Hâ‚‚Oâ‚‚ fogging sterilization, and dry humidity control without standing water. It provided quicker turnaround, reduced contamination risk, and effectively addressed GMP compliance requirements.
October 2024 marked the launch by Eppendorf of CellXpert CS220, a COâ‚‚ incubator shaker with an integral 180°C sterilisation cycle. Designed to suit mammalian cell culture, it improved upon contamination protection, held more flasks, featured a streamlined chamber for easy cleaning, and packed a compact build with the smallest platform-to-footprint ratio on the market.
Thermo Fisher Scientific in June 2024 introduced the IntelliStack Incubator and COâ‚‚ Incubator Shakers fully integrated with accurate and reproducible control of cell culture. The stackable instruments had a 10-inch touchscreen, 5L capacity, and versatile configurations with COâ‚‚ and non-COâ‚‚ shakers. The solution addresses biotech, biopharma, and academic markets, enables automated cell therapy manufacturing, and mitigates the risk of contamination.
Automated Cell Shakers Market Report Scope
|
Report Attribute |
Details |
|
Market size value in 2025 |
USD 747.2 million |
|
Revenue forecast in 2030 |
USD 1.05 billion |
|
Growth rate |
CAGR of 7.10% from 2025 to 2030 |
|
Actual Data |
2018 - 2024 |
|
Forecast period |
2025 - 2030 |
|
Quantitative units |
Revenue in USD million/billion, and CAGR from 2025 to 2030 |
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
|
Segments covered |
Product, application, end-use, region |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
|
Country scope |
U.S.; Canada; Mexico; Germany; UK; France; Italy; Spain; Sweden; Denmark; Norway; China; Japan; India; South Korea; Australia; Thailand; Brazil; Argentina; Saudi Arabia; Kuwait; UAE; South Africa |
|
Key companies profiled |
Thermo Fisher Scientific Inc.; Eppendorf AG; Ohaus Corporation; Benchmark Scientific; Corning Incorporated; Grant Instruments; Kuhner Shaker; Infors AG; Boekel Scientific; VELP Scientifica Srl |
|
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
|
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
Global Automated Cell Shakers Market Report Segmentation
-
Product Outlook (Revenue, USD Million, 2018 - 2030)
-
Automated Cell Shakers
-
Orbital Shakers
-
Benchtop Incubator Shakers
-
Cell Shaker with Rotatory Arms
-
Accessories
-
Others
-
-
Application Outlook (Revenue, USD Million, 2018 - 2030)
-
Drug Development
-
Regenerative Medicine
-
Cell Therapy
-
Stem Cell Research
-
-
End-use Outlook (Revenue, USD Million, 2018 - 2030)
-
Pharmaceutical Companies
-
Biopharmaceutical Companies,
-
CDMOs & CMOs
-
Hospitals
-
Other End Use
-
-
Regional Outlook (Revenue, USD Million, 2018 - 2030)
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Sweden
-
Denmark
-
Norway
-
-
Asia Pacific
-
China
-
Japan
-
India
-
South Korea
-
Australia
-
Thailand
-
-
Latin America
-
Brazil
-
Argentina
-
-
Middle East and Africa (MEA)
-
South Africa
-
UAE
-
Saudi Arabia
-
Kuwait
-
-
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy